Exome analysis of HIV patients submitted to dendritic cells therapeutic vaccine reveals an association of CNOT1 gene with response to the treatment

Journal of the International AIDS Society

Volumn 17, Issue , 2014, Pages

  Moura, Ronald ^a   Pontillo, Alessandra ^b   D'Adamo, Pio ^c   Pirastu, Nicola ^c   Coelho, Antonio Campos ^a   Crovella, Sergio ^c  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

CNOT1; DC immunotherapy; Exome analysis; HIV; TTP

Indexed keywords

DENDRITIC CELL VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INACTIVATED VACCINE; MESSENGER RNA; TRISTETRAPROLIN;

ADENYLATION; ARTICLE; BRAZIL; CCR4 NOT TRANSCRIPTION COMPLEX SUBUNIT 1 GENE; CLINICAL ARTICLE; EXOME; EXOME ANALYSIS; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INTRON; NONSENSE MEDIATED MRNA DECAY; PRIORITY JOURNAL; QUALITY CONTROL; REGULATORY MECHANISM; RNA PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; VACCINATION; VIRUS REPLICATION;

CNOT1; DC IMMUNOTHERAPY; EXOME ANALYSIS; HIV; TTP;

AIDS VACCINES; DENDRITIC CELLS; EXOME; HIV INFECTIONS; HUMANS; IMMUNITY, HUMORAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS; TREATMENT OUTCOME;

EID: 84896822363     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.17.1.18938     Document Type: Article

References (18)

1. García F, Routy JP. Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1. Vaccine. 2011;29(38):6454-63.
2. García F, Climent N, Guardo AC, Gil C, León A, Autran B, et al. DCV2/MANON07-ORVACS Study Group. A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication. Sci Transl Med. 2013;5(166):166ra2.
3. Lu W, Arraes LC, Ferreira WT, Andrieu JM. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat Med. 2004;12:1359-65. (Pubitemid 40022718)
4. An P, Winkler CA. Host genes associated with HIV/AIDS: advances in gene discovery. Trends Genet. 2010;26(3):119-31.
5. Segat L, Brandão LA, Guimarães RL, Pontillo A, Athanasakis E, de Oliveira RM, et al. Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment. Vaccine. 2010;28(10):2201-6.
6. Goldstein JI, Crenshaw A, Carey J, Grant GB, Maguire J, Fromer M, et al. zCall: a rare variant caller for array-based genotyping. Bioinformatics. 2012;28(19):2543-5.
7. Aulchenko YS, Ripke S, Isaacs A, van Duijn CM. GenABEL: an R library for genome-wide association analysis. Bioinformatics. 2007;23(10):1294-6. (Pubitemid 47050548)
8. Devlin B, Roeder K, Wasserman L. Genomic control, a new approach to genetic-based association studies. Theor Popul Biol. 2001;60(3):155-66. (Pubitemid 34235086)
9. Wang K, Abbott D. A principal components regression approach to multilocus genetic association studies. Genet Epidemiol. 2008;32(2):108-18. (Pubitemid 351288028)
10. Ito K, Takahashi A, Morita M, Suzuki T, Yamamoto T. The role of the CNOT1 subunit of the CCR4-NOT complex in mRNA deadenylation and cell viability. Protein Cell. 2011;2(9):755-63.
11. Garneau NL, Wilusz J, Wilusz CJ. The highways and byways of mRNA decay. Nat Rev Mol Cell Biol. 2007;8(2):113-26. (Pubitemid 46432531)
12. Paul P, van den Hoorn T, Jongsma ML, Bakker MJ, Hengeveld R, Janssen L, et al. A genome-wide multidimensional RNAi screen reveals pathways controlling MHC class II antigen presentation. Cell. 2011;145(2):268-83.
13. Fabian MR, Frank F, Rouya C, Siddiqui N, Lai WS, Karetnikov A, et al. Structural basis for the recruitment of the human CCR4-NOT deadenylase complex by tristetraprolin. Nat Struct Mol Biol. 2013;20(6):735-9.
14. Maeda M, Sawa H, Tobiume M, Tokunaga K, Hasegawa H, Ichinohe T, et al. Tristetraprolin inhibits HIV-1 production by binding to genomic RNA. Microbes Infect. 2006;8(11):2647-56. (Pubitemid 44573880)
15. McMichael AJ, Borrow P, Tomaras GD, Goonetilleke N, Haynes BF. The immune response during acute HIV-1 infection: clues for vaccine development. Nat Rev Immunol. 2010;10(1):11-23.
16. Kaufmann DE, Rosenberg ES. The value of preserving HIV-specific immune responses. J HIV Ther. 2003;8(1):19-25.
17. Miedema F, Hazenberg MD, Tesselaar K, van Baarle D, de Boer RJ, Borghans JA. Immune activation and collateral damage in AIDS pathogenesis. Front Immunol. 2013;4:298.
18. Pontillo A, Silva LT, Oshiro TM, Finazzo C, Crovella S, Duarte AJ. HIV-1 induces NALP3-inflammasome expression and interleukin-1β secretion in dendritic cells from healthy individuals but not from HIV-positive patients. AIDS. 2012;26(1):11-8.